- Home
- ANTX vs APYX Comparison
ANTX vs APYX Comparison
Compare ANTX & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- APYX
- Stock Information
- Founded
- ANTX 2017
- APYX 1982
- Country
- ANTX United States
- APYX United States
- Employees
- ANTX N/A
- APYX N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- ANTX Health Care
- APYX Health Care
- Exchange
- ANTX Nasdaq
- APYX Nasdaq
- Market Cap
- ANTX 37.3M
- APYX 36.8M
- IPO Year
- ANTX 2022
- APYX 1987
- Fundamental
- Price
- ANTX $1.20
- APYX $1.16
- Analyst Decision
- ANTX Buy
- APYX Hold
- Analyst Count
- ANTX 4
- APYX 2
- Target Price
- ANTX $2.00
- APYX N/A
- AVG Volume (30 Days)
- ANTX 133.7K
- APYX 54.9K
- Earning Date
- ANTX 05-16-2025
- APYX 05-08-2025
- Dividend Yield
- ANTX N/A
- APYX N/A
- EPS Growth
- ANTX N/A
- APYX N/A
- EPS
- ANTX N/A
- APYX N/A
- Revenue
- ANTX N/A
- APYX $47,288,000.00
- Revenue This Year
- ANTX N/A
- APYX $1.85
- Revenue Next Year
- ANTX N/A
- APYX $7.72
- P/E Ratio
- ANTX N/A
- APYX N/A
- Revenue Growth
- ANTX N/A
- APYX N/A
- 52 Week Low
- ANTX $0.87
- APYX $0.76
- 52 Week High
- ANTX $3.07
- APYX $1.99
- Technical
- Relative Strength Index (RSI)
- ANTX 43.48
- APYX 54.22
- Support Level
- ANTX $1.05
- APYX $1.04
- Resistance Level
- ANTX $1.29
- APYX $1.31
- Average True Range (ATR)
- ANTX 0.07
- APYX 0.13
- MACD
- ANTX -0.00
- APYX 0.03
- Stochastic Oscillator
- ANTX 54.55
- APYX 69.07
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.